(Q36763684)

16 August 2017

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer (English)

1 reference

16 August 2017

1 reference

13

Noah D Kauff

1 reference

16 August 2017

10

Kenneth Offit

1 reference

16 August 2017

11

Richard R Barakat

1 reference

16 August 2017

3

Alexia Iasonos

1 reference

16 August 2017

4

Rachel N Grisham

1 reference

16 August 2017

9

Carol Aghajanian

1 reference

16 August 2017

David M Hyman

1

1 reference

16 August 2017

Qin Zhou

2

1 reference

16 August 2017

Angela G Arnold

5

1 reference

16 August 2017

Mary F Phillips

6

1 reference

16 August 2017

Jasmine Bhatia

7

1 reference

16 August 2017

Douglas A Levine

8

1 reference

16 August 2017

David R Spriggs

12

1 reference

16 August 2017

language of work or name

English

0 references

publication date

2 December 2011

1 reference

16 August 2017

1 reference

16 August 2017

118

1 reference

16 August 2017

15

1 reference

16 August 2017

3703-3709

1 reference

Integrated genomic analyses of ovarian carcinoma

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

29 September 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Meta-analysis of BRCA1 and BRCA2 penetrance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Improved survival in BRCA2 carriers with ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Relative frequency of primary ovarian neoplasms: a 10-year review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Analysis of survival by tumor response.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Improved survival in women with BRCA-associated ovarian carcinoma

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625663

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26655

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26655

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26655

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

21 January 2018

1 reference

12 December 2020

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers

1 reference

12 December 2020

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

12 December 2020

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1

1 reference

12 December 2020

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

1 reference

12 December 2020

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.26655

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

22139894

1 reference